Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

NASDAQ:MNTK - Nasdaq - US61218C1036 - Common Stock - Currency: USD

2.26  -0.11 (-4.64%)

After market: 2.26 0 (0%)

Fundamental Rating

5

MNTK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. MNTK has only an average score on both its financial health and profitability. MNTK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

MNTK had positive earnings in the past year.
In the past year MNTK had a positive cash flow from operations.
MNTK had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MNTK had a positive operating cash flow.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

With a decent Return On Assets value of 2.09%, MNTK is doing good in the industry, outperforming 68.42% of the companies in the same industry.
MNTK has a Return On Equity of 2.87%. This is comparable to the rest of the industry: MNTK outperforms 57.89% of its industry peers.
MNTK's Return On Invested Capital of 4.45% is amongst the best of the industry. MNTK outperforms 84.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MNTK is above the industry average of 3.78%.
Industry RankSector Rank
ROA 2.09%
ROE 2.87%
ROIC 4.45%
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

With a Profit Margin value of 4.13%, MNTK perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
In the last couple of years the Profit Margin of MNTK has remained more or less at the same level.
With a Operating Margin value of 9.62%, MNTK perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
In the last couple of years the Operating Margin of MNTK has declined.
MNTK has a Gross Margin (43.01%) which is comparable to the rest of the industry.
MNTK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.62%
PM (TTM) 4.13%
GM 43.01%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MNTK is destroying value.
MNTK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MNTK has been increased compared to 5 years ago.
MNTK has a better debt/assets ratio than last year.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MNTK has an Altman-Z score of 2.93. This is not the best score and indicates that MNTK is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.93, MNTK belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that MNTK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.16, MNTK belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 2.93
ROIC/WACC0.52
WACC8.59%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

MNTK has a Current Ratio of 1.27. This is a normal value and indicates that MNTK is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.27, MNTK is doing good in the industry, outperforming 63.16% of the companies in the same industry.
MNTK has a Quick Ratio of 1.27. This is a normal value and indicates that MNTK is financially healthy and should not expect problems in meeting its short term obligations.
MNTK has a Quick ratio of 1.27. This is in the better half of the industry: MNTK outperforms 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

MNTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.29%.
The Earnings Per Share has been growing by 11.33% on average over the past years. This is quite good.
MNTK shows a decrease in Revenue. In the last year, the revenue decreased by -7.71%.
Measured over the past years, MNTK shows a quite strong growth in Revenue. The Revenue has been growing by 10.70% on average per year.
EPS 1Y (TTM)-64.29%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-100%
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%9.84%

3.2 Future

MNTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.07% yearly.
The Revenue is expected to grow by 9.17% on average over the next years. This is quite good.
EPS Next Y44.5%
EPS Next 2Y48.66%
EPS Next 3Y51.2%
EPS Next 5Y25.07%
Revenue Next Year-13.17%
Revenue Next 2Y-0.84%
Revenue Next 3Y9.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.1 0.2 0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MNTK is valuated quite expensively with a Price/Earnings ratio of 45.20.
Compared to the rest of the industry, the Price/Earnings ratio of MNTK is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.32, MNTK is valued quite expensively.
Based on the Price/Forward Earnings ratio of 17.04, the valuation of MNTK can be described as rather expensive.
84.21% of the companies in the same industry are more expensive than MNTK, based on the Price/Forward Earnings ratio.
MNTK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.2
Fwd PE 17.04
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNTK is valued cheaply inside the industry as 89.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.04
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

MNTK's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as MNTK's earnings are expected to grow with 51.20% in the coming years.
PEG (NY)1.02
PEG (5Y)3.99
EPS Next 2Y48.66%
EPS Next 3Y51.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTAUK RENEWABLES INC

NASDAQ:MNTK (6/17/2025, 8:00:01 PM)

After market: 2.26 0 (0%)

2.26

-0.11 (-4.64%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners15.79%
Inst Owner Change-1.69%
Ins Owners54%
Ins Owner Change0%
Market Cap321.89M
Analysts44.44
Price Target2.93 (29.65%)
Short Float %2.26%
Short Ratio7.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-161.92%
Min EPS beat(2)-223.84%
Max EPS beat(2)-100%
EPS beat(4)1
Avg EPS beat(4)-103.63%
Min EPS beat(4)-223.84%
Max EPS beat(4)23.84%
EPS beat(8)2
Avg EPS beat(8)-57.49%
EPS beat(12)2
Avg EPS beat(12)-61.89%
EPS beat(16)3
Avg EPS beat(16)-39.63%
Revenue beat(2)0
Avg Revenue beat(2)-26.64%
Min Revenue beat(2)-51.79%
Max Revenue beat(2)-1.5%
Revenue beat(4)1
Avg Revenue beat(4)-14.26%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)5.8%
Revenue beat(8)2
Avg Revenue beat(8)-10.55%
Revenue beat(12)3
Avg Revenue beat(12)-10.8%
Revenue beat(16)6
Avg Revenue beat(16)-6.14%
PT rev (1m)-8%
PT rev (3m)-45.88%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-80%
EPS NY rev (1m)0%
EPS NY rev (3m)-51.43%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)-33.44%
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-25.53%
Valuation
Industry RankSector Rank
PE 45.2
Fwd PE 17.04
P/S 1.79
P/FCF N/A
P/OCF 8.33
P/B 1.25
P/tB 1.34
EV/EBITDA 8.04
EPS(TTM)0.05
EY2.21%
EPS(NY)0.13
Fwd EY5.87%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.27
OCFY12%
SpS1.26
BVpS1.81
TBVpS1.69
PEG (NY)1.02
PEG (5Y)3.99
Profitability
Industry RankSector Rank
ROA 2.09%
ROE 2.87%
ROCE 5.51%
ROIC 4.45%
ROICexc 5.1%
ROICexgc 5.46%
OM 9.62%
PM (TTM) 4.13%
GM 43.01%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
ROICexc(3y)11.17%
ROICexc(5y)7.39%
ROICexgc(3y)12.1%
ROICexgc(5y)8%
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexcg growth 3Y40.95%
ROICexcg growth 5Y0.62%
ROICexc growth 3Y41%
ROICexc growth 5Y0.44%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.98
Cap/Depr 213.47%
Cap/Sales 28.94%
Interest Coverage 4.19
Cash Conversion 92.86%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.93
F-Score4
WACC8.59%
ROIC/WACC0.52
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.29%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-100%
EPS Next Y44.5%
EPS Next 2Y48.66%
EPS Next 3Y51.2%
EPS Next 5Y25.07%
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%9.84%
Revenue Next Year-13.17%
Revenue Next 2Y-0.84%
Revenue Next 3Y9.17%
Revenue Next 5YN/A
EBIT growth 1Y-58.2%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year9.46%
EBIT Next 3Y12.97%
EBIT Next 5Y10.19%
FCF growth 1Y-150.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.2%
OCF growth 3Y0.71%
OCF growth 5Y9.49%